Gala Global Products Ltd vs Nestle India Ltd

A side-by-side comparison of Gala Global Products Ltd (GGPL) and Nestle India Ltd (NESTLEIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Nestle India Ltd leads GGPL vs NESTLEIND on 11 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

14.91
P/E ratio
84.46
0.30
P/B ratio
52.54
0.00%
Dividend yield
0.98%
₹0.11
EPS
₹17.19

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

-11.82%
Return on equity
67.85%
-1.82%
Return on capital
96.00%
-2.90%
EBITDA margin
24.00%
-10.75%
Net margin
16.40%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-39.89%
Revenue CAGR (3Y)
6.58%
Profit CAGR (3Y)
5.28%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹10 Cr
Market cap
₹2.74L Cr
₹42 Cr
Revenue
₹20,202 Cr
₹-4 Cr
Net profit
₹3,314 Cr
1.05
Debt / equity
0.08
Gala Global Products Ltd
  • + ["Stock is trading at 0.30 times its book value"]
  • ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -29.4% over past five years.", "Promoter holding is low: 0.15%", "Company has a low return on equity of -10.4% over last 3 years.", "Promoter holding has decreased over last 3 years: -48.4%"]
Nestle India Ltd
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 92.3%", "Company has been maintaining a healthy dividend payout of 74.3%"]
  • ["Stock is trading at 51.8 times its book value", "The company has delivered a poor sales growth of 11.6% over past five years."]
Gala Global Products Ltd full analysis Nestle India Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.